Provided by Tiger Trade Technology Pte. Ltd.

Ovid Therapeutics Inc.

2.82
+0.02000.71%
Post-market: 2.820.00000.00%16:20 EDT
Volume:1.23M
Turnover:3.44M
Market Cap:549.90M
PE:-11.12
High:2.86
Open:2.79
Low:2.67
Close:2.80
52wk High:3.11
52wk Low:1.05
Shares:195.00M
Float Shares:163.00M
Volume Ratio:0.68
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2535
EPS(LYR):-0.2325
ROE:-25.96%
ROA:-23.46%
PB:2.62
PE(LYR):-12.13

Loading ...

Oppenheimer Sticks to Its Buy Rating for Ovid Therapeutics (OVID)

TIPRANKS
·
Aug 14

Wedbush Keeps Their Buy Rating on Ovid Therapeutics (OVID)

TIPRANKS
·
Aug 14

Ovid Therapeutics Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Ovid Therapeutics Releases Corporate Presentation Outlining Neural Hyperexcitability Drug Pipeline

Reuters
·
Aug 13

Ovid Therapeutics Q2 Revenue Beats Estimates

Reuters
·
Aug 13

Ovid Q2 FY26 Net Loss Widens to $15 Million; Operating Expenses Rise to $16.4 Million

Reuters
·
Aug 13

Ovid Therapeutics Q2 Revenue USD 733 Thousand VS. Ibes Estimate USD 0

THOMSON REUTERS
·
Aug 13

Ovid Therapeutics Q2 EPS USD -0.08

THOMSON REUTERS
·
Aug 13

Ovid Therapeutics Inc. Expected to Post a Loss of 11 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Ovid Therapeutics CFO Charles Ross Files Initial Beneficial Ownership Statement

Reuters
·
Jul 09

Ovid Therapeutics CFO Jeffrey Rona to step down, Charles Carter to succeed

TIPRANKS
·
Jul 08

Ovid Therapeutics Names Kevin Norrett Chief Business Officer

Reuters
·
Jul 08

Ovid Therapeutics - Promotes Charles Carter to Chief Financial Officer

THOMSON REUTERS
·
Jul 08

Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development

THOMSON REUTERS
·
Jul 08

Ovid Therapeutics director Anna Greka files initial beneficial ownership statement

Reuters
·
Jun 18

Ovid Therapeutics shareholders approve executive pay advisory proposal at annual meeting

Reuters
·
Jun 11

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Ovid Therapeutics (OVID) and Establishment Labs Holdings (ESTA)

TIPRANKS
·
Jun 09

Ovid Therapeutics to present at Oppenheimer CNS & Neuro-Muscular Summit

Reuters
·
Jun 04

Ovid Therapeutics names Anna Greka to board of directors

Reuters
·
Jun 03

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.d., Ph.d., to Board of Directors

THOMSON REUTERS
·
Jun 03